MY116595A - Polycarboxylic based cross-linked copolymers - Google Patents

Polycarboxylic based cross-linked copolymers

Info

Publication number
MY116595A
MY116595A MYPI97004035A MYPI9704035A MY116595A MY 116595 A MY116595 A MY 116595A MY PI97004035 A MYPI97004035 A MY PI97004035A MY PI9704035 A MYPI9704035 A MY PI9704035A MY 116595 A MY116595 A MY 116595A
Authority
MY
Malaysia
Prior art keywords
based cross
polycarboxylic
linked copolymers
copolymers
polycarboxylic based
Prior art date
Application number
MYPI97004035A
Inventor
El-Matni Nada
Fessi Hatem
Labarre Denis
Original Assignee
Ipsen Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma Sas filed Critical Ipsen Pharma Sas
Publication of MY116595A publication Critical patent/MY116595A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • C08F8/32—Introducing nitrogen atoms or nitrogen-containing groups by reaction with amines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Graft Or Block Polymers (AREA)

Abstract

THE INVENTION RELATES TO RETICULATED COPOLYMERS CONTAINING NON-RETICULATED POLYCARBOXYLIC POLYMERS, SAID COPOLYMERS CONTAINING AT LEAST A POLYCARBOXYLIC POLYSACCHARIDE. THE INVENTION RELATES ALSO TO A PROCESS FOR THE PREPARATION OF SAID COPOLYMERS AND THEIR USE, PARTICULARLY AS SUPPORT FOR PHARMACEUTICAL COMPOSITIONS.
MYPI97004035A 1996-08-30 1997-08-30 Polycarboxylic based cross-linked copolymers MY116595A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9610601A FR2752843B1 (en) 1996-08-30 1996-08-30 CROSSLINKED COPOLYMERS BASED ON POLYCARBOXYLIC POLYMERS AND THEIR USE AS SUPPORTS OF PHARMACEUTICAL COMPOSITIONS

Publications (1)

Publication Number Publication Date
MY116595A true MY116595A (en) 2004-02-28

Family

ID=9495309

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI97004035A MY116595A (en) 1996-08-30 1997-08-30 Polycarboxylic based cross-linked copolymers

Country Status (20)

Country Link
EP (1) EP0922071B1 (en)
JP (1) JP4162265B2 (en)
AT (1) ATE208803T1 (en)
AU (1) AU730566B2 (en)
CA (1) CA2266645C (en)
CZ (1) CZ296041B6 (en)
DE (1) DE69708304T2 (en)
DK (1) DK0922071T3 (en)
ES (1) ES2167784T3 (en)
FR (1) FR2752843B1 (en)
HU (1) HUP9903745A3 (en)
IL (1) IL128619A (en)
MY (1) MY116595A (en)
NO (1) NO311621B1 (en)
NZ (1) NZ334301A (en)
PL (1) PL193227B1 (en)
PT (1) PT922071E (en)
RU (1) RU2194055C2 (en)
WO (1) WO1998008897A1 (en)
ZA (1) ZA977671B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303738B1 (en) * 1998-11-11 2001-02-23 Aquisitio S P A CARBOXYLATE POLYSACCHARIDE CROSS-LINKING PROCESS.
IT1303735B1 (en) * 1998-11-11 2001-02-23 Falorni Italia Farmaceutici S CROSS-LINKED HYALURONIC ACIDS AND THEIR MEDICAL USES.
US6288043B1 (en) * 1999-06-18 2001-09-11 Orquest, Inc. Injectable hyaluronate-sulfated polysaccharide conjugates
FR2799196B1 (en) * 1999-10-04 2002-02-08 Sod Conseils Rech Applic CROSSLINKED COPOLYMERS BASED ON NON-CROSSLINKED POLYCARBOXYLIC COPOLYMERS
KR100378109B1 (en) * 2000-10-24 2003-03-29 주식회사 메디프렉스 Hydrophobic multicomponant heparin conjugates, a preparing method and a use thereof
JP4796845B2 (en) * 2003-07-18 2011-10-19 日本エクスラン工業株式会社 Amino acid derivative sustained-release polymer, cosmetics and fiber structure containing the polymer, and methods for producing and regenerating them
FR2873379B1 (en) * 2004-07-23 2008-05-16 Jerome Asius PROCESS FOR THE PREPARATION OF RETICULATED HYALURONIC ACID, RETICULATED HYALURONIC ACID WHICH CAN BE OBTAINED BY THIS METHOD, IMPLANT CONTAINING THE RETICULATED HYALURONIC ACID, AND USE THEREOF
GB2423252B (en) * 2005-02-18 2007-10-17 Engelhard Lyon Cross-linked polymer of carbohydrate, notably based on polysaccharides, and/or on oligosaccharides and/or on polyols
CN101432311A (en) * 2006-02-28 2009-05-13 诺维信生物聚合物公司 Derivatives of hyaluronic acids
EP1942117A1 (en) * 2006-12-29 2008-07-09 Sigea S.R.L. Derivatives of acid polysaccharides
WO2009047802A2 (en) * 2007-10-10 2009-04-16 Lupin Limited Novel colon targeted modified release bioadhesive formulation of 5-amino salicylic acid or its salts and metabolites thereof
EP3184552B1 (en) 2008-09-02 2020-08-12 Tautona Group LP Threads of hyaluronic acid, methods of making thereof and uses thereof
CZ302789B6 (en) * 2009-11-25 2011-11-09 Zentiva, K. S. Method of increasing solubility of pharmaceutically active compounds and targeted (controlled) transport thereof into intestine
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
DK3078388T3 (en) 2010-03-22 2019-05-20 Allergan Inc CROSS-BREAKED HYDROGEN WAVES
CN107412002A (en) 2011-06-03 2017-12-01 阿勒根公司 Dermal filler composition including antioxidant
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
FR2997014B1 (en) 2012-10-24 2015-03-20 Teoxane DERMO-INJECTABLE STERILE COMPOSITION
ITUD20130119A1 (en) * 2013-09-12 2015-03-13 Limacorporate Spa BIOCOMPATIBLE IDROGEL FOR BIOMEDICAL OR PHARMACEUTICAL USE, INTERMEDIATE POLYMER TO REALIZE THE BIOCOMPATIBLE IDROGEL AND ITS APPLICATION METHOD
ES2811269T3 (en) * 2014-01-31 2021-03-11 Seikagaku Kogyo Co Ltd Diamine crosslinking agent, acid polysaccharide crosslinking body and medical material
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
EP3386551A4 (en) * 2015-12-11 2018-10-24 The General Hospital Corporation Dextran nanoparticles for macrophage specific imaging and therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4026851A (en) * 1975-08-13 1977-05-31 E. I. Du Pont De Nemours And Company Acrylate polymers cured with diamines in the presence of an acid catalyst
US4663050A (en) * 1982-01-18 1987-05-05 Standard Oil Company Semipermeable membranes prepared from polymers containing adjacent, pendent carboxy groups
US4937270A (en) * 1987-09-18 1990-06-26 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US5017229A (en) * 1990-06-25 1991-05-21 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
DE3809764A1 (en) * 1988-03-23 1989-10-05 Knoll Ag MIXTURE OF ALGINATES AND POLYACRYLATES AND THEIR USE
DE527942T1 (en) * 1990-05-04 1994-03-03 Perio Prod Ltd DISPENSING SYSTEM IN COLON.

Also Published As

Publication number Publication date
IL128619A0 (en) 2000-01-31
FR2752843A1 (en) 1998-03-06
HUP9903745A3 (en) 2001-03-28
IL128619A (en) 2004-02-19
HUP9903745A2 (en) 2000-03-28
WO1998008897A1 (en) 1998-03-05
NO990935D0 (en) 1999-02-26
CA2266645C (en) 2008-03-18
PL331848A1 (en) 1999-08-16
AU730566B2 (en) 2001-03-08
ZA977671B (en) 1998-02-23
ATE208803T1 (en) 2001-11-15
ES2167784T3 (en) 2002-05-16
RU2194055C2 (en) 2002-12-10
DE69708304D1 (en) 2001-12-20
JP2001501228A (en) 2001-01-30
DE69708304T2 (en) 2002-07-25
AU4121597A (en) 1998-03-19
NZ334301A (en) 2000-06-23
NO990935L (en) 1999-04-15
EP0922071B1 (en) 2001-11-14
FR2752843B1 (en) 1998-10-16
JP4162265B2 (en) 2008-10-08
PL193227B1 (en) 2007-01-31
PT922071E (en) 2002-05-31
NO311621B1 (en) 2001-12-17
CZ60699A3 (en) 2000-06-14
DK0922071T3 (en) 2002-03-11
CZ296041B6 (en) 2005-12-14
CA2266645A1 (en) 1998-03-05
EP0922071A1 (en) 1999-06-16

Similar Documents

Publication Publication Date Title
MY116595A (en) Polycarboxylic based cross-linked copolymers
AU4867697A (en) Oxadiazoles, processes for preparing them and their use as pharmaceutical compositions
ZA200006299B (en) Biodegradable sustained-release alginate gels.
HUP9700328A3 (en) Heteroaryl-oxazolidinones, process for their preparation, pharmaceutical compositions containing the same, their use and intermediates
IL126038A0 (en) Novel benzothiepines and derivatives thereof and pharmaceutical compositions comprising them
EP1129683A4 (en) Hyaluronic acid gel, process for the preparation thereof and medical materials containing the same
HUP9603495A3 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
IT1283630B1 (en) PROCESS FOR THE PREPARATION OF EP (D) M ELASTOMERIC COPOLYMERS
ZA974735B (en) Pharmaceutical compositions.
HU9700903D0 (en) Sulfonamide-substituted chromanes, process for producing them, their use as pharmaceutical compositions or diagnostica, and pharmaceutical compositions containing them
AUPP589598A0 (en) Novel peptides
AU4133997A (en) Pharmaceutical composition for the treatment of syndrome x of reaven
FR2715402B1 (en) New phenylimidazolines optionally substituted, their process and preparation intermediates, their use as medicaments and the pharmaceutical compositions containing them.
ZA977104B (en) Pharmaceutical compositions.
EP0919576A4 (en) Novel copolymer, process for the preparation of the same, and use thereof
AU7670600A (en) Crosslinked copolymers based on non-crosslinked polycarboxylic copolymers
HU9700989D0 (en) Ortho-substituted benzoyl-guanidines, process for producing them, their use as medicament and diagnosticment, pharmaceutical compositions containing them
HUP9601331A3 (en) Piperazine- and homopiperazine-derivatives, process for producing them and pharmaceutical compositions containing them
AU642793B2 (en) Catalyst compositions and process for the preparation of polymers
ZA972602B (en) Pharmaceutical compositions.
AU1606997A (en) Novel naphthylpiperazines derived from substituted cycloazanes, method for preparing same, pharmaceutical compositions and use thereof as drugs
ZA972708B (en) Pharmaceutical compositions and methods for the manufacture thereof.
IL129624A0 (en) Novel (+)-enantiomers of CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
DE69726602D1 (en) Hepatitis b inhibitoren
AU4040299A (en) Hair treatment composition containing particles of macroporous, highly cross-linked polymer